Table 1.
Male patient age, male patient body mass index (BMI), female patient age and anti-Mullerian hormone (AMH) in the whole studied population of patients with TZs.
| DGC-SU (N = 100) |
DGC (N = 99) |
SU (N = 92) |
DGC-MACS (N = 94) |
p-Value | |
|---|---|---|---|---|---|
| Male patient age (Years) | 34.89 ± 3.9 | 34.90 ± 4.50 | 34.9 ± 646 | 39.07 ± 8.59 | 0.93 |
| Male patient BMI (Kg/m2) | 25.34 ± 3.46 | 25.25 ± 3.1 | 24.5 ± 3.02 | 25.39 ± 2.98 | 0.09 |
| Infertility duration (Years) | 9.32 ± 5.38 | 9.54 ± 5.57 | 9.24 ± 6.42 | 10.34 ± 6.16 | 0.19 |
| Female patient age (Years) | 30.7 ± 5.31 | 30.86 ± 5.61 | 31.8 ± 6.08 | 33.01 ± 5.42 | 0.28 |
| Female patient BMI (Kg/m2) | 27.10 ± 4.52 | 28.95 ± 2.58 | 28.78 ± 3.66 | 28.14 ± 3.81 | 0.49 |
| AMH (ng/mL) | 3.98 ± 2.94 | 4 ± 3.70 | 3.30 ± 3.30 | 3.6 ± 3.5 | 0.56 |
| Total gonadotropin dose (IU) | 2529 ± 1536 | 2539 ± 1878 | 2925 ± 1755 | 2625 ± 1834 | 0.92 |
| Total gonadotropin dose/oocyte | 647.6 ± 891 | 605 ± 1079 | 747 ± 1011 | 651 ± 987 | 0.72 |
| Stimulation days | 15 ± 3 | 15 ± 2 | 14.5 ± 2.8 | 15 ± 2 | 0.89 |
| Estradiol level on the day of HCG (pg/mL) | 1974 ± 1316 | 1791 ± 1076 | 2040 ± 1408 | 1804 ± 1601 | 0.38 |
| Estradiol level/oocyte | 237 ± 385 | 220 ± 302 | 202 ± 304 | 200 ± 392 | 0.586 |
Values represent mean ± SD.